"diseases and treatment" trang 4 - tải miễn phí từ tailieunhanh
Ethnoveterinary medicine a practical approach to the treatment of cattle diseases in sub-Saharan Africa

Ethnoveterinary medicine a practical approach to the treatment of cattle diseases in sub-Saharan Africa

88    70    0
báo cáo hóa học:

báo cáo hóa học:" Emerging role of microRNAs in diagnosis and treatment of various diseases including ovarian cancer"
9    60    0
Báo cáo y học:

Báo cáo y học: "The potential of human regulatory T cells generated ex vivo as a treatment for lupus and other chronic inflammatory diseases"
6    74    0
Báo cáo y học:

Báo cáo y học: "The impact of infliximab treatment on quality of life in patients with inflammatory rheumatic diseases"
6    64    1
Treatment of Tuberculosis - American Thoracic Society, CDC, and Infectious Diseases Society of America

Treatment of Tuberculosis - American Thoracic Society, CDC, and Infectious Diseases Society of America
88    53    0
Báo cáo y học:

Báo cáo y học: " A novel small molecule target in human airway smooth muscle for potential treatment of obstructive lung diseases: a staged highthroughput biophysical screening"
9    54    0
Báo cáo y học:

Báo cáo y học: "Spleen tyrosine kinase inhibition in the treatment of autoimmune, allergic and autoinflammatory diseases'
11    58    0
Báo cáo y học:

Báo cáo y học: "Antibodies toward infliximab are associated with low infliximab concentration at treatment initiation and poor infliximab maintenance in rheumatic diseases"
7    47    0
ALLERGIC DISEASES – HIGHLIGHTS IN THE CLINIC, MECHANISMS AND TREATMENT

ALLERGIC DISEASES – HIGHLIGHTS IN THE CLINIC, MECHANISMS AND TREATMENT

566    53    0
Báo cáo khoa học: Treatment of neutral glycosphingolipid lysosomal storage diseases via inhibition of the ABC drug transporter, MDR1 Cyclosporin A can lower serum and liver globotriaosyl ceramide levels in the Fabry mouse model

Báo cáo khoa học: Treatment of neutral glycosphingolipid lysosomal storage diseases via inhibition of the ABC drug transporter, MDR1 Cyclosporin A can lower serum and liver globotriaosyl ceramide levels in the Fabry mouse model
12    63    0
Allergic Diseases – Highlights in the Clinic, Mechanisms and Treatment Edited by Celso Pereira

Allergic Diseases – Highlights in the Clinic, Mechanisms and Treatment Edited by Celso Pereira
566    42    0
The Report of The Constitution Project’s Task Force on Detainee Treatment

The Report of The Constitution Project’s Task Force on Detainee Treatment
577    36    0
Ebook ABC of dermatology (4/E): Part 1

Ebook ABC of dermatology (4/E): Part 1
73    86    0
Antimicrobial peptides: A potential therapeutic alternative for the treatment of fish diseases

Antimicrobial peptides: A potential therapeutic alternative for the treatment of fish diseases
7    92    0
Diagnosis & treatment neurology with current (Third edition): Part 2

Diagnosis & treatment neurology with current (Third edition): Part 2
340    63    0
Intestinal microbiota composition after antibiotic treatment in early life: The INCA study

Intestinal microbiota composition after antibiotic treatment in early life: The INCA study
8    70    0
Unclogging seed borne pathogens to prevent diseases in Capsicum

Unclogging seed borne pathogens to prevent diseases in Capsicum
8    55    1
Improvement of locomotive syndrome with surgical treatment in patients with degenerative diseases in the lumbar spine and lower extremities: A prospective cohort study

Improvement of locomotive syndrome with surgical treatment in patients with degenerative diseases in the lumbar spine and lower extremities: A prospective cohort study
10    38    1
Development and validation of the General Rehabilitation Adherence Scale (GRAS) in patients attending physical therapy clinics for musculoskeletal disorders

Development and validation of the General Rehabilitation Adherence Scale (GRAS) in patients attending physical therapy clinics for musculoskeletal disorders
11    58    2
High hopes for cannabinoid agonists in the treatment of rheumatic diseases

High hopes for cannabinoid agonists in the treatment of rheumatic diseases
5    24    1